Objective: To identify mutations and variants in CASQ2 gene in 27 CPVT patients/family members.
Methods: Mutational analysis was performed with direct DNA sequence analysis. The frequency of an identified CASQ2 variant was determined using the Taqman genotyping assay.
Results: A novel heterozygous mutation, F189L, in CASQ2 gene was identified in one family with CPVT. This mutation occurred at the evolutionarily, highly conserved phenylalanine residue at codon 189, and was not present in 1400 control individuals. No other disease-causing mutations were identified in the CASQ2 gene.
Conclusion: A novel mutation of F189L in the CASQ2 gene was identified.
Download full-text PDF |
Source |
---|
Stem Cell Res
December 2024
Clinic for Cardiology and Pneumology, Georg-August University Göttingen and DZHK (German Center for Cardiovascular Research), Partner Site, Göttingen, Germany; Institute of Pharmacology and Toxicology, University of Würzburg, Würzburg, Germany. Electronic address:
Takotsubo Syndrome (TTS) is a potentially life-threatening disease characterized by a transient left ventricular apical akinesia in response to β-adrenergic overstimulation. Since a genetic predisposition is assumed, we generated an iPSC-line carrying a p.F189L mutation in the calcium buffering protein Calsequestrin 2 (CasQ2).
View Article and Find Full Text PDFCell Physiol Biochem
March 2011
Department of Biochemistry I, Ruhr-University Bochum, Bochum, Germany.
Rationale: The plateau phase of the ventricular action potential is the result of balanced Ca(2+) influx and K(+) efflux. The action potential is terminated by repolarizing K(+) currents. Under β-adrenergic stimulation, both the Ca(2+)-influx and the delayed rectifier K(+) currents I(K) are stimulated to adjust the cardiac action potential duration to the enhanced heart rate and to ascertain adequate increase in net Ca(2+) influx.
View Article and Find Full Text PDFZhonghua Yi Xue Yi Chuan Xue Za Zhi
June 2008
Department of Cardiology, Peopleos Hospital of Peking University, Beijing, 100044 People's Republic of China.
Objective: To identify mutations and variants in CASQ2 gene in 27 CPVT patients/family members.
Methods: Mutational analysis was performed with direct DNA sequence analysis. The frequency of an identified CASQ2 variant was determined using the Taqman genotyping assay.
Mol Cell Biol
June 2000
Molecular and Cell Biology Department, University of California, Berkeley, California 94720, USA.
Many proteins that contain a carboxyl-terminal CaaX sequence motif, including Ras and yeast a-factor, undergo a series of sequential posttranslational processing steps. Following the initial prenylation of the cysteine, the three C-terminal amino acids are proteolytically removed, and the newly formed prenylcysteine is carboxymethylated. The specific amino acids that comprise the CaaX sequence influence whether the protein can be prenylated and proteolyzed.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!